These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 12460554)
1. The HD mutation does not alter neuronal death in the striatum of Hdh(Q92) knock-in mice after mild focal ischemia. Namura S; Hirt L; Wheeler VC; McGinnis KM; Hilditch-Maguire P; Moskowitz MA; MacDonald ME; Persichetti F Neurobiol Dis; 2002 Oct; 11(1):147-54. PubMed ID: 12460554 [TBL] [Abstract][Full Text] [Related]
2. Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Kuhn A; Goldstein DR; Hodges A; Strand AD; Sengstag T; Kooperberg C; Becanovic K; Pouladi MA; Sathasivam K; Cha JH; Hannan AJ; Hayden MR; Leavitt BR; Dunnett SB; Ferrante RJ; Albin R; Shelbourne P; Delorenzi M; Augood SJ; Faull RL; Olson JM; Bates GP; Jones L; Luthi-Carter R Hum Mol Genet; 2007 Aug; 16(15):1845-61. PubMed ID: 17519223 [TBL] [Abstract][Full Text] [Related]
3. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958 [TBL] [Abstract][Full Text] [Related]
4. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Kim YJ; Yi Y; Sapp E; Wang Y; Cuiffo B; Kegel KB; Qin ZH; Aronin N; DiFiglia M Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12784-9. PubMed ID: 11675509 [TBL] [Abstract][Full Text] [Related]
5. Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease. Yu ZX; Li SH; Evans J; Pillarisetti A; Li H; Li XJ J Neurosci; 2003 Mar; 23(6):2193-202. PubMed ID: 12657678 [TBL] [Abstract][Full Text] [Related]
7. Light and electron microscopic characterization of the evolution of cellular pathology in HdhQ92 Huntington's disease knock-in mice. Bayram-Weston Z; Jones L; Dunnett SB; Brooks SP Brain Res Bull; 2012 Jun; 88(2-3):171-81. PubMed ID: 21513775 [TBL] [Abstract][Full Text] [Related]
8. Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. Kim M; Lee HS; LaForet G; McIntyre C; Martin EJ; Chang P; Kim TW; Williams M; Reddy PH; Tagle D; Boyce FM; Won L; Heller A; Aronin N; DiFiglia M J Neurosci; 1999 Feb; 19(3):964-73. PubMed ID: 9920660 [TBL] [Abstract][Full Text] [Related]
11. Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo. Graham RK; Deng Y; Carroll J; Vaid K; Cowan C; Pouladi MA; Metzler M; Bissada N; Wang L; Faull RL; Gray M; Yang XW; Raymond LA; Hayden MR J Neurosci; 2010 Nov; 30(45):15019-29. PubMed ID: 21068307 [TBL] [Abstract][Full Text] [Related]
12. Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway. Ruan Q; Lesort M; MacDonald ME; Johnson GV Hum Mol Genet; 2004 Apr; 13(7):669-81. PubMed ID: 14962977 [TBL] [Abstract][Full Text] [Related]
13. Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis. Reis SA; Thompson MN; Lee JM; Fossale E; Kim HH; Liao JK; Moskowitz MA; Shaw SY; Dong L; Haggarty SJ; MacDonald ME; Seong IS Hum Mol Genet; 2011 Jun; 20(12):2344-55. PubMed ID: 21447599 [TBL] [Abstract][Full Text] [Related]
14. Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity. Cowan CM; Fan MM; Fan J; Shehadeh J; Zhang LY; Graham RK; Hayden MR; Raymond LA J Neurosci; 2008 Nov; 28(48):12725-35. PubMed ID: 19036965 [TBL] [Abstract][Full Text] [Related]
15. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Wheeler VC; White JK; Gutekunst CA; Vrbanac V; Weaver M; Li XJ; Li SH; Yi H; Vonsattel JP; Gusella JF; Hersch S; Auerbach W; Joyner AL; MacDonald ME Hum Mol Genet; 2000 Mar; 9(4):503-13. PubMed ID: 10699173 [TBL] [Abstract][Full Text] [Related]
16. The selective vulnerability of nerve cells in Huntington's disease. Sieradzan KA; Mann DM Neuropathol Appl Neurobiol; 2001 Feb; 27(1):1-21. PubMed ID: 11298997 [TBL] [Abstract][Full Text] [Related]
17. Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice. Menalled LB; Sison JD; Wu Y; Olivieri M; Li XJ; Li H; Zeitlin S; Chesselet MF J Neurosci; 2002 Sep; 22(18):8266-76. PubMed ID: 12223581 [TBL] [Abstract][Full Text] [Related]
18. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length. Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890 [TBL] [Abstract][Full Text] [Related]